Source Bioscience Limited
Official name: Source Bioscience Limited (trading as Source LDPath)
86 capabilities
Verified Sep 2026
One of 2,380 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
1 Orchard Place, Business Park
Nottingham NG8 6PX , United Kingdom
Nottingham NG8 6PX , United Kingdom
Accreditation
Active
UKAS
9571
sourcebioscience.com
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
9571
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (86)
| Standard Reference | Description | Category |
|---|---|---|
| Digital images from slides | Morphological assessment and Slide scanning using 3DHISTECH | Digital images from slides | Morphological assessment and Slide scanning using 3DHISTECH | Histopathology / Cytology |
| FFPE Tissue | Breast carcinoma GCDFP-15 | FFPE tissue | Breast carcinoma GCDFP-15 | Histopathology / Cytology |
| FFPE Tissue | Cytokeratin (pan) Pan-CK (AE1/AE3) | FFPE Tissue | Cytokeratin (pan) Pan-CK (AE1/AE3) | Histopathology / Cytology |
| FFPE Tissue | Cytoplasm of ductal or lobular CK8/18 | FFPE Tissue | Cytoplasm of ductal or lobular CK8/18 | Histopathology / Cytology |
| FFPE Tissue | Demonstration of cytokeratins CK5/6 | FFPE Tissue | Demonstration of cytokeratins CK5/6 | Histopathology / Cytology |
| FFPE Tissue | Detection of activated CD68 | FFPE Tissue | Detection of activated CD68 | Histopathology / Cytology |
| FFPE Tissue | Endothelial marker CD31 | FFPE Tissue | Endothelial marker CD31 | Histopathology / Cytology |
| FFPE Tissue | Gastrointestinal epithelia CK20 | FFPE Tissue | Gastrointestinal epithelia CK20 | Histopathology / Cytology |
| FFPE Tissue | Lymphatic endothelium D2-40 (Podoplanin) | FFPE Tissue | Lymphatic endothelium D2-40 (Podoplanin) | Histopathology / Cytology |
| FFPE Tissue | MLH1 mismatch repair protein MLH1 | FFPE Tissue | MLH1 mismatch repair protein MLH1 | Histopathology / Cytology |
| FFPE Tissue | MSH2 mismatch repair protein MSH2 | FFPE Tissue | MSH2 mismatch repair protein MSH2 | Histopathology / Cytology |
| FFPE Tissue | MSH6 mismatch repair protein MSH6 | FFPE Tissue | MSH6 mismatch repair protein MSH6 | Histopathology / Cytology |
| FFPE Tissue | Malignant melonomas CD63 | FFPE Tissue | Malignant melonomas CD63 | Histopathology / Cytology |
| FFPE Tissue | Mature B cells, follicular CD10 | FFPE Tissue | Mature B cells, follicular CD10 | Histopathology / Cytology |
| FFPE Tissue | Melanocytic tumours SOX10 | FFPE Tissue | Melanocytic tumours SOX10 | Histopathology / Cytology |
| FFPE Tissue | Ovarian cancer/HPV p16 | FFPE Tissue | Ovarian cancer/HPV p16 | Histopathology / Cytology |
| FFPE Tissue | P40 protein. P40 is selectively p40 | FFPE Tissue | P40 protein. P40 is selectively p40 | Histopathology / Cytology |
| FFPE Tissue | PMS2 mismatch repair protein PMS2 | FFPE Tissue | PMS2 mismatch repair protein PMS2 | Histopathology / Cytology |
| FFPE Tissue | Proliferating cells Ki67 | FFPE Tissue | Proliferating cells Ki67 | Histopathology / Cytology |
| FFPE Tissue | SOP-137 | FFPE Tissue | SOP-137 | Histopathology / Cytology |
| FFPE tissue blocks | HM325 and Lieca RM2135 | FFPE tissue blocks | HM325 and Lieca RM2135 | Histopathology / Cytology |
| FFPE tissue slides | (H&E) Staining ST5020 Multistainer and CV5030 | FFPE tissue slides | (H&E) Staining ST5020 Multistainer and CV5030 | Histopathology / Cytology |
| FFPE tissue | (DPAS): ONC-SOP-26 | FFPE tissue | (DPAS): ONC-SOP-26 | Histopathology / Cytology |
| FFPE tissue | Activated T & B cells CD31 | FFPE tissue | Activated T & B cells CD31 | Histopathology / Cytology |
| FFPE tissue | Adrenocortical Carcinomas | FFPE tissue | Adrenocortical Carcinomas | Histopathology / Cytology |
| FFPE tissue | B cells CD20 | FFPE tissue | B-cells CD20 | Histopathology / Cytology |
| FFPE tissue | Basal cells of squamous P63 | FFPE tissue | Basal cells of squamous P63 | Histopathology / Cytology |
| FFPE tissue | Connective Tissue SOP-34 | FFPE tissue | Connective Tissue SOP-34 | Histopathology / Cytology |
| FFPE tissue | Cytokeratin (pan) AE1/AE3 | FFPE tissue | Cytokeratin (pan) AE1/AE3 | Histopathology / Cytology |
| FFPE tissue | Endothelia CD34 | FFPE tissue | Endothelia CD34 | Histopathology / Cytology |
| FFPE tissue | Epithelia | FFPE tissue | Epithelia | Histopathology / Cytology |
| FFPE tissue | Ferric Iron Pearls Prussian Blue; TCL-SOP-33 | FFPE tissue | Ferric Iron Pearls Prussian Blue; TCL-SOP-33 | Histopathology / Cytology |
| FFPE tissue | Follicular epithelial cells of the TTF-1 | FFPE tissue | Follicular epithelial cells of the TTF-1 | Histopathology / Cytology |
| FFPE tissue | Fungi | FFPE tissue | Fungi | Histopathology / Cytology |
| FFPE tissue | Fungi (DPAS): TCL-SOP-40 | FFPE tissue | Fungi (DPAS): TCL-SOP-40 | Histopathology / Cytology |
| FFPE tissue | Fungi SOP-25 | FFPE tissue | Fungi SOP-25 | Histopathology / Cytology |
| FFPE tissue | Glandular, transitional CK7 | FFPE tissue | Glandular, transitional CK7 | Histopathology / Cytology |
| FFPE tissue | Glycogen SOP-40 | FFPE tissue | Glycogen SOP-40 | Histopathology / Cytology |
| FFPE tissue | HER2 HER2 (4B5) | FFPE tissue | HER2 HER2 (4B5) | Histopathology / Cytology |
| FFPE tissue | HER2 gene amplification Fluorescent in situ hybridisation | FFPE tissue | HER2 gene amplification Fluorescent in situ hybridisation | Histopathology / Cytology |
| FFPE tissue | Melanoma PRAME | FFPE tissue | Melanoma PRAME | Histopathology / Cytology |
| FFPE tissue | Melanoma, S100+ neoplasms, S100 | FFPE tissue | Melanoma, S100+ neoplasms, S100 | Histopathology / Cytology |
| FFPE tissue | Melanoma, melanosomes HMB45 | FFPE tissue | Melanoma, melanosomes HMB45 | Histopathology / Cytology |
| FFPE tissue | Mixed (ABPAS): TCL-SOP-42 | FFPE tissue | Mixed (ABPAS): TCL-SOP-42 | Histopathology / Cytology |
| FFPE tissue | Neutral Mucins | FFPE tissue | Neutral mucins | Histopathology / Cytology |
| FFPE tissue | ONC-SOP-34 | FFPE tissue | ONC-SOP-34 | Histopathology / Cytology |
| FFPE tissue | ONC-SOP-93 | FFPE tissue | ONC-SOP-93 | Histopathology / Cytology |
| FFPE tissue | Oestrogen receptor ER (SP1) | FFPE tissue | Oestrogen receptor ER (SP1) | Histopathology / Cytology |
| FFPE tissue | P40 P40 | FFPE tissue | P40 P40 | Histopathology / Cytology |
| FFPE tissue | Progesterone receptor PR (1E2) | FFPE tissue | Progesterone receptor PR (1E2) | Histopathology / Cytology |
| FFPE tissue | Proliferating cells Ki67 (MIB-1) | FFPE tissue | Proliferating cells Ki67 (MIB-1) | Histopathology / Cytology |
| FFPE tissue | Reticulin fibres Reticulin; TCL-SOP-45 | FFPE tissue | Reticulin fibres Reticulin; TCL-SOP-45 | Histopathology / Cytology |
| FFPE tissue | SMM | FFPE tissue | SMM | Histopathology / Cytology |
| FFPE tissue | SOP-7 | FFPE tissue | SOP-7 | Histopathology / Cytology |
| FFPE tissue | Squamous Epithelia CK5 | FFPE tissue | Squamous Epithelia CK5 | Histopathology / Cytology |
| FFPE tissue | Squamous and basal epithelia CK14 | FFPE tissue | Squamous and basal epithelia CK14 | Histopathology / Cytology |
| FFPE tissue | Squamous and myoepithelia CK5/6 | FFPE tissue | Squamous and myoepithelia CK5/6 | Histopathology / Cytology |
| FFPE tissue | T cells CD3 | FFPE tissue | T cells CD3 | Histopathology / Cytology |
| FFPE tissue | TCL-SOP-19 | FFPE tissue | TCL-SOP-19 | Histopathology / Cytology |
| Fixed tissue blocks | SOP-34 | Fixed tissue blocks | SOP-34 | Histopathology / Cytology |
| Fixed tissue | 16 | Fixed tissue | 16 | Histopathology / Cytology |
| Fixed tissue | ONC-SOP-73, ONC-SOP-74. | Fixed tissue | ONC-SOP-73, ONC-SOP-74. | Histopathology / Cytology |
| Fixed tissue | Processing Sakura VIP6 A1: ONC-SOP-34. | Fixed tissue | Processing Sakura VIP6 A1: ONC-SOP-34. | Histopathology / Cytology |
| Fixed tissue | SOP-11 | Fixed tissue | SOP-11 | Histopathology / Cytology |
| Fixed tissue | SOP-18 | Fixed tissue | SOP-18 | Histopathology / Cytology |
| Fixed tissue, FFPE tissue | SOP-34 | Fixed tissue, FFPE tissue | SOP-34 | Histopathology / Cytology |
| Fixed, Slides | Up Procedure | Fixed, Slides | Up Procedure | Histopathology / Cytology |
| HUMAN BODY TISSUES | accordance with ONC-SOP-92 | HUMAN BODY TISSUES | accordance with ONC-SOP-92 | Histopathology / Cytology |
| DNA extracted from FFPE | BRAF Qiagen pyromark Q24 and Q96 | DNA extracted from FFPE | BRAF Qiagen pyromark Q24 and Q96 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-28 | DNA extracted from FFPE | Gene-SOP-28 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-29 | DNA extracted from FFPE | Gene-SOP-29 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-58 | DNA extracted from FFPE | Gene-SOP-58 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-59 | DNA extracted from FFPE | Gene-SOP-59 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-6 | DNA extracted from FFPE | Gene-SOP-6 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-60 | DNA extracted from FFPE | Gene-SOP-60 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | Gene-SOP-89 | DNA extracted from FFPE | Gene-SOP-89 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | KRAS Qiagen pyromark Q24 and Q96 | DNA extracted from FFPE | KRAS Qiagen pyromark Q24 and Q96 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | NRAS Qiagen pyromark Q24 and Q96 | DNA extracted from FFPE | NRAS Qiagen pyromark Q24 and Q96 | Molecular Diagnostics / PCR |
| Tissue (FFPE) | Gene-SOP-81 | Tissue (FFPE) | Gene-SOP-81 | Molecular Diagnostics / PCR |
| Tissue (FFPE) | Purification Gene-SOP-25 | Tissue (FFPE) | Purification Gene-SOP-25 | Molecular Diagnostics / PCR |
| DNA extracted from FFPE | EGFR Qiagen pyromark Q24 platform and | DNA extracted from FFPE | EGFR Qiagen pyromark Q24 platform and | Other |
| FFPE tissue | Class 1 Immunohistochemistry Performed on the Ventana Ultra in | FFPE tissue | Class 1 Immunohistochemistry Performed on the Ventana Ultra in | Other |
| FFPE tissue | Class 2 Immunohistochemistry Performed on the Ventana Ultra in | FFPE tissue | Class 2 Immunohistochemistry Performed on the Ventana Ultra in | Other |
| Fixed tissue | Processing HistoCore PELORIS 3: TCL-SOP- | Fixed tissue | Processing HistoCore PELORIS 3: TCL-SOP- | Other |
| Fixed, Slides | TCL-SOP-6 Decalcifying and | Fixed, Slides | TCL-SOP-6 Decalcifying and | Other |
| HUMAN BODY TISSUES | Class 1 Immunohistochemistry Performed on the Ventana Ultra in | HUMAN BODY TISSUES | Class 1 Immunohistochemistry Performed on the Ventana Ultra in | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.